Search Results

There are 60150 results for: content related to: Oxidative stress as a cause of Parkinson's disease

  1. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  2. You have free access to this content
    MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 582–593, GuoQi Zhu, YuYing Huang, Ying Chen, YingHan Zhuang and Thomas Behnisch

    Version of Record online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07815.x

  3. You have free access to this content
    Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Journal of Neurochemistry

    Volume 122, Issue 5, September 2012, Pages: 1032–1046, Sophie Schumm, Claude Sebban, Charles Cohen-Salmon, Jacques Callebert, Jean-Marie Launay, Jean-Louis Golmard, Lydie Boussicault, Isabelle Petropoulos, Audrey Hild, Estelle Rousselet, Annick Prigent, Bertrand Friguet, Jean Mariani and Etienne C. Hirsch

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1471-4159.2012.07837.x

  4. The pharmacology of the parkinsonian syndrome producing neurotoxin MPTP (1–methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and structurally related compounds

    Medicinal Research Reviews

    Volume 6, Issue 4, October/December 1986, Pages: 389–429, S. P. Markey and N. R. Schmuff

    Version of Record online : 18 SEP 2006, DOI: 10.1002/med.2610060402

  5. Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds

    Journal of Neurochemistry

    Volume 61, Issue 4, October 1993, Pages: 1191–1206, Keith F. Tipton and Thomas P. Singer

    Version of Record online : 15 DEC 2006, DOI: 10.1111/j.1471-4159.1993.tb13610.x

  6. 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced neurotoxicity in the rat: Characterization and age-dependent effects

    Synapse

    Volume 5, Issue 2, 1990, Pages: 104–112, Dr. Michael F. Jarvis and George C. Wagner

    Version of Record online : 12 OCT 2004, DOI: 10.1002/syn.890050204

  7. Pathophysiology and Biochemical Mechanisms Involved in MPTP-Induced Parkinsonism

    Journal of the American Geriatrics Society

    Volume 35, Issue 7, July 1987, Pages: 660–668, Dr. Judes Poirier

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1987.tb04343.x

  8. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 12, December 2015, Pages: 1849–1864, Lacey Pflibsen, Katherine A. Stang, Michelle D. Sconce, Vanessa B. Wilson, Rebecca L. Hood, Charles K. Meshul and Suzanne H. Mitchell

    Version of Record online : 31 AUG 2015, DOI: 10.1002/jnr.23638

  9. Neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A model for parkinson's disease and its therapy

    Drug Development Research

    Volume 15, Issue 1, 1988, Pages: 1–15, Dr. F. V. DeFeudis

    Version of Record online : 5 OCT 2004, DOI: 10.1002/ddr.430150102

  10. MPTP-induced parkinsonism as a model for Parkinson's disease

    Acta Neurologica Scandinavica

    Volume 80, Issue s126, November 1989, Pages: 35–40, J. W. Tetrud and J. W. Langston

    Version of Record online : 29 JAN 2009, DOI: 10.1111/j.1600-0404.1989.tb01780.x

  11. Poster session 1: A. Basic science, genetics, neuropharmacology, Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S17–S64,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10349

  12. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  13. Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys

    Glia

    Volume 56, Issue 11, 15 August 2008, Pages: 1199–1214, Nicholas M. Kanaan, Jeffrey H. Kordower and Timothy J. Collier

    Version of Record online : 15 MAY 2008, DOI: 10.1002/glia.20690

  14. Acute Effects of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of Debrisoquine

    Journal of Neurochemistry

    Volume 57, Issue 1, July 1991, Pages: 81–87, Félix Javier Jiménez-Jiménez, César Tabernero, María Angeles Mena, Justo García de Yébenes, María Jesús García de Yébenes, María José Casarejos, Beatriz Pardo, José Augusto García-Agundez, Julio Benítez, Armando Martínez and José Antonio López García-Asenjo

    Version of Record online : 5 OCT 2006, DOI: 10.1111/j.1471-4159.1991.tb02102.x

  15. You have free access to this content
    The Neurotoxicity of MPTP and the Relevance to Parkinson's Disease

    Pharmacology & Toxicology

    Volume 67, Issue 1, July 1990, Pages: 8–13, J. M. McCrodden, K. F. Tipton and J. P. Sullivan

    Version of Record online : 25 MAR 2009, DOI: 10.1111/j.1600-0773.1990.tb00773.x

  16. Novel observations with FDOPA-PET imaging after early nigrostriatal damage

    Movement Disorders

    Volume 16, Issue 5, September 2001, Pages: 838–848, R.E. Yee, I. Irwin, C. Milonas, D.B. Stout, S-C. Huang, K. Shoghi-Jadid, N. Satyamurthy, L.E. Delanney, D.M. Togasaki, K.F. Farahani, K. Delfani, A.M. Janson, M.E. Phelps, J.W. Langston and J.R. Barrio

    Version of Record online : 30 AUG 2001, DOI: 10.1002/mds.1168

  17. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

    Journal of Neuroscience Research

    Volume 88, Issue 7, 15 May 2010, Pages: 1522–1536, Hironori Yokoyama, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato and Tsutomu Araki

    Version of Record online : 8 DEC 2009, DOI: 10.1002/jnr.22310

  18. 2-Deoxyglucose Enhances 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine-Induced ATP Loss in the Mouse Brain

    Journal of Neurochemistry

    Volume 61, Issue 2, August 1993, Pages: 610–616, Piu Chan, J. William Langston, Ian Irwin, Louis E. DeLanney and Donate A. Di Monte

    Version of Record online : 5 OCT 2006, DOI: 10.1111/j.1471-4159.1993.tb02165.x

  19. The Significance of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine

    Ciba Foundation Symposium 126 - Selective Neuronal Death

    C. D. Marsden, P. G. Jenner, Pages: 239–256, 2007

    Published Online : 28 SEP 2007, DOI: 10.1002/9780470513422.ch15

  20. You have free access to this content
    A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism

    Genes, Brain and Behavior

    Volume 12, Issue 2, March 2013, Pages: 224–233, A. Dhanushkodi, E. O. Akano, E. E. Roguski, Y. Xue, S. K. Rao, S. G. Matta, T. S. Rex and M. P. McDonald

    Version of Record online : 28 NOV 2012, DOI: 10.1111/gbb.12001